CIEL Limited, a diversified conglomerate with operations in Africa and Asia, has announced its financial results for the year ending June 2026. The group reported a net profit after tax of Rs 4.3 billion, representing a 13% increase from the previous year. This growth was driven by a strong performance across various sectors, including hospitality, finance, healthcare, and textiles. The company's revenue increased by 8% to Rs 41.2 billion.
The company's hospitality segment, which includes hotels and resorts, contributed significantly to the growth in revenue. Additionally, the healthcare segment, which operates in Mauritius and Uganda, continued to show improvement. The textile business in India also maintained its momentum, offsetting a relatively modest performance from regional textile operations. The company's financial services segment also reported improved banking revenues.
CIEL Limited's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased by 18% to Rs 8.5 billion, resulting in a margin of 20.6%. The company's profit attributable to shareholders rose by 4% to Rs 2.3 billion, or Rs 1.33 per share. The group's cash generation was strong, with a free cash flow of Rs 4.9 billion. This will enable the company to pursue strategic investments in healthcare, hotel renovations, and the development of a medical device manufacturing platform in India.
The company's debt profile remains stable, with a net debt of Rs 16.4 billion and a debt-to-equity ratio of 29.6%. CIEL Limited has declared a dividend of Rs 0.35 per share. The company's diversified operations span six sectors: textiles, financial services, healthcare, hospitality, real estate, and agriculture, with a presence in over 10 countries in Africa and Asia. The group employs approximately 37,500 people.
CIEL Limited's growth strategy is focused on executing its plans, generating cash, and managing capital discipline. According to Guillaume Dalais, Group Chief Executive of CIEL Limited, "The investments made in healthcare, hospitality, and medical device manufacturing open up new growth prospects in the markets where we operate." The company was founded in 1912 and has a long history of operations in Africa and Asia.
The company's diversified portfolio and strong financial performance position it for continued growth and expansion. CIEL Limited's investments in strategic sectors, such as healthcare and hospitality, are expected to drive future growth. The company's commitment to disciplined capital management and cash generation will also support its long-term objectives.
Looking ahead, CIEL Limited is well-positioned to capitalize on emerging opportunities in its markets. The company's diversified operations and strong financial performance provide a solid foundation for future growth. With a long history of operations and a commitment to strategic investments, CIEL Limited is poised for continued success.
Key points
- CIEL Limited reports a 13% increase in net profit to Rs 4.3 billion for 2026.
- The company's revenue increases by 8% to Rs 41.2 billion.
- CIEL Limited's EBITDA rises by 18% to Rs 8.5 billion.
